Neostigmine Injection, 0.5 MG/ML, 1 MG/ML
Neostigmine Injection, 0.5 MG/ML, 1 MG/ML - Image 2
Categories:, , SKU: 00004-115
Neostigmine Injection, 0.5 MG/ML, 1 MG/ML

Download as PDF
Enquire Now

Description

PRODUCT DESCRIPTION:

 

Neostigmine Injection is a cholinesterase inhibitor used to reverse the effects of non-depolarizing muscle relaxants after surgery and to manage conditions characterized by muscle weakness, such as myasthenia gravis.

It enhances neuromuscular transmission by inhibiting the breakdown of acetylcholine, thereby improving muscle strength and tone.

This injectable formulation is widely employed in post-operative recovery, critical care, and neurology departments to counteract residual neuromuscular blockade and support breathing function.

Formulation & Presentation:

  • Dosage Form: Sterile Injectable
  • Presentation: Clear Sterile Solution in Clear/Amber Glass Vial/ Ampoule (customizable as per market demand)
  • Available Strengths:
    • Neostigmine: 0.5 MG/ ML
    • Neostigmine: 1 MG/ML
  • Route of Administration: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC). To be used after appropriate reconstitution or as per clinical indication and recommendation. Reconstituted as per protocol for injection in country of use. To be administered under strict supervision of a qualified doctor or as per physician’s discretion or decision only.

Therapeutic Indications:

  • Reversal of non-depolarizing neuromuscular blockade post-surgery
  • Management of myasthenia gravis
  • Postoperative bladder distension and urinary retention

Side Effects:

  • COMMON:
    • Increased salivation
    • Nausea and vomiting
    • Abdominal cramps
    • Bradycardia (slow heart rate)
    • Sweating and dizziness
  • SERIOUS (RARE):
    • Severe bradycardia or cardiac arrest
    • Respiratory depression
    • Hypersensitivity reactions including anaphylaxis
    • Seizures or muscle fasciculations
    • Excessive cholinergic stimulation (cholinergic crisis)
  • PRECAUTIONS:
    • Use cautiously in patients with asthma, bradycardia, or hypotension
    • Avoid concurrent use with other cholinergic agents without supervision
    • Anticholinergic agents (e.g., atropine) should be available to counteract muscarinic effects
    • Monitor ECG and respiratory status during administration
    • Not recommended during pregnancy unless clinically necessary

Reviews

There are no reviews yet.

Be the first to review “Neostigmine Injection, 0.5 MG/ML, 1 MG/ML”

Your email address will not be published. Required fields are marked *

12345

TECHNICAL INFORMATION

Product Specifications:

  • HSN Code: To be assigned per international classification standards & import jurisdiction
  • Weight: Approx. 40g per Carton (With Packaging)
  • Dimensions: (15x1x8 CMS)
  • Shelf Life (Subject To Country Specific Guidelines): 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications
  • Storage: Store below 25°C strictly Only (Do not freeze). Does not require cold-chain logistics. Vial/Ampoule to be stored strictly at recommended temperature range only. Protect from moisture, direct sunlight & children.

Regulatory Status & Supply Information:

  • Regulatory Status: WHO-GMP Complaint Manufacturing. COA, MSDS, Stability Data, Manufacturing Batch Record, Dossier Support (on request). Further certifications available on request
  • Exports Ready Dossiers: COA, COPP, Dossier Available (CTD/eCTD formats). Complies with USP/EP/BP Standards
  • Stability: Compliant
  • MOQ: Negotiable. Based on market & registration status
  • Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

  • Hospitals and Surgical Centers
  • Anesthesia Departments and Recovery Units
  • Critical Care and Neurology Clinics
  • Importers & Distributors of Emergency Care Drugs
  • Healthcare NGOs working in surgical & post-op recovery support

Why Source from PHARMET?

  • Single-window sourcing for diverse pharma needs
  • Export-ready documentation & regulatory support
  • Adaptable documentation support for effective registration support
  • Trusted consortium network, simplifying India’s complex pharma supply chain
  • Multiple approved manufacturers for best fit in import country
  • Network of audited, compliant manufacturers across India
  • Customizable & Flexible branding, packaging & formulation flexibility
  • End to End Logistics support flexibility & support
  • Deep expertise in exporting specialty injectables & all products

CONTACT DETAILS:

Related items